ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,608Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1171

$1.74M Total Retail Price of All Prescriptions

Rank: 5 out of 1171

779 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 779 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 779 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 27,178 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 1,260 1,164 1 6
WARFARIN SODIUM 1,245 1,132 2 12
SIMVASTATIN 1,151 1,032 3 1
LISINOPRIL 907 749 4 3
AMLODIPINE BESYLATE 821 729 5 2
OMEPRAZOLE 810 694 6 5
LEVOTHYROXINE SODIUM 779 703 7 4
NAMENDA 701 697 8 42
TRAMADOL HCL 594 535 9 18
METOPROLOL TARTRATE 579 533 10 11
MIRTAZAPINE 536 512 11 50
DONEPEZIL HCL 521 508 12 24
QUETIAPINE FUMARATE 508 433 13 54
GABAPENTIN 492 401 14 16
HYDRALAZINE HCL 357 337 15 60
LANTUS 345 303 16 46
TAMSULOSIN HCL 341 306 17 28
HYDROCHLOROTHIAZIDE 338 318 18 9
CLONIDINE HCL 334 258 19 45
TRAZODONE HCL 322 272 20 37
CARVEDILOL 321 276 21 20
CITALOPRAM HBR 316 302 22 22
KLOR-CON M20 312 282 23 41
ATENOLOL 305 270 24 15
ATORVASTATIN CALCIUM 288 220 25 10
PREDNISONE 274 250 26 39
PANTOPRAZOLE SODIUM 254 186 27 29
SERTRALINE HCL 253 216 28 23
RISPERIDONE 251 249 29 77
METOPROLOL SUCCINATE 240 224 30 17
FAMOTIDINE 226 212 31 75
POTASSIUM CHLORIDE 217 203 32 19
KLOR-CON M10 216 200 33 125
HYDROCODONE-ACETAMINOPHEN 208 205 S3 34 8
SEROQUEL 207 185 35 120
LOSARTAN POTASSIUM 204 189 36 14
ALLOPURINOL 199 178 37 31
DIOVAN 196 163 38 32
METFORMIN HCL 192 167 39 7
CYMBALTA 186 137 40 64
PRAVASTATIN SODIUM 184 155 41 13
LEVETIRACETAM 183 170 42 84
GLIPIZIDE 181 179 43 47
CLOPIDOGREL 180 162 44 35
IPRATROPIUM-ALBUTEROL 180 174 44 130
DIGOXIN 174 172 46 68
LIDODERM 171 166 47 98
ISOSORBIDE MONONITRATE ER 152 134 48 44
PAROXETINE HCL 151 129 49 62
METOCLOPRAMIDE HCL 151 130 49 141
ESCITALOPRAM OXALATE 148 123 51 69
JANUVIA 147 131 52 66
CEPHALEXIN 147 129 52 104
NOVOLOG 144 128 54 94
PLAVIX 135 118 55 55
CARBIDOPA-LEVODOPA 129 123 56 107
AVELOX 129 124 56 209
CIPROFLOXACIN HCL 125 105 58 61
NOVOLIN R 113 92 59 155
FINASTERIDE 110 109 60 88
TRAVATAN Z 108 107 61 223
INSULIN SYRINGE 107 81 62 71
ADVAIR DISKUS 106 91 63 51
ABILIFY 105 72 64 175
DIVALPROEX SODIUM 105 87 64 106
DILTIAZEM 24HR CD 104 89 66 101
HUMALOG 102 87 67 132
EXELON 101 101 68 164
NEXIUM 98 95 69 25
SPIRONOLACTONE 94 93 70 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 93 84 71 109
CLONIDINE 92 83 72 229
LEVEMIR 92 76 72 167
VENLAFAXINE HCL ER 91 74 74 113
RANITIDINE HCL 90 87 75 38
CELEBREX 90 88 75 100
LEVOFLOXACIN 87 83 77 105
COLCRYS 86 80 78 159
ZOLPIDEM TARTRATE 85 68 79 21
ALENDRONATE SODIUM 84 84 80 33
HALOPERIDOL 82 65 81 176
OXYBUTYNIN CHLORIDE ER 82 69 81 135
ENALAPRIL MALEATE 81 73 83 73
TRICOR 80 68 84 140
FLUTICASONE PROPIONATE 79 54 85 30
LIPITOR 77 64 86 92
ZETIA 73 66 87 63
AGGRENOX 73 61 87 148
SPIRIVA 71 63 89 57
LEVEMIR FLEXPEN 71 68 89 145
NIFEDIPINE ER 71 56 89 114
LOVASTATIN 71 68 89 36
BACLOFEN 71 44 89 110
COMBIVENT 69 58 94 152
CRESTOR 69 29 94 27
LEXAPRO 67 62 96 222
NYSTATIN-TRIAMCINOLONE 66 58 97 264
ISOSORBIDE DINITRATE 65 59 98 213
SANTYL 65 59 98 173
DIOVAN HCT 65 57 98 65
NYSTATIN 64 50 101 128
GENERLAC 64 45 101 374
ACTOS 63 59 103 123
PHENYTOIN 61 41 104 256
LACTULOSE 61 50 104 108
LYRICA 61 49 104 127
AMOX TR-POTASSIUM CLAVULANATE 61 51 104 142
NITROFURANTOIN MONO-MACRO 60 60 108 210
SINGULAIR 58 45 109 78
DORZOLAMIDE-TIMOLOL 55 55 110 320
AZITHROMYCIN 55 52 110 43
GLIPIZIDE XL 55 36 110 124
MEGACE ES 54 54 R 113 446
TIMOLOL MALEATE 54 51 113 302
ACETAMINOPHEN-CODEINE 53 51 S3 115 121
VALACYCLOVIR 53 49 115 448
PHENYTOIN SODIUM EXTENDED 53 39 115 137
PRIMIDONE 52 52 118 320
MEGESTROL ACETATE 52 47 R 118 185
MELOXICAM 51 43 120 56
FLUOXETINE HCL 50 50 121 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.